You are here

Multiple sclerosis

YEDA-XL-Protein GmbH Agreement
21.10.2014

Combining two technologies makes a drug compound stronger and longer-lasting

HIV and cell membrane. Image:ThinkStock
16.01.2014

The molecule that helps HIV invade immune cells might, in the future, help prevent autoimmune attacks

Yeda Research and Development Company, Ltd.
19.05.2013
 
Yeda Research and Development Company, Ltd., was established in 1959 to...
Prof. Michael Sela
10.10.2010
from the institute to Teva Pharmaceuticals Ltd.
Prof. Ephraim Katzir
12.09.2010
In the 1950s, Prof. Ephraim Katzir developed simple synthetic models, known as polyamino acids, that...
Prof. Michel Revel
08.09.2010

Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the...

Genes that affect reponses of MS to Copaxone
10.10.2007

Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®

...
Wrapping Up
26.06.2007
Weizmann Institute Scientists reveal a mechanism for healthy nerve development, which may...
Prof. Avraham Ben-Nun.
01.05.2001

Genetically engineered "draw-fire" proteins may lead to a new treatment for autoimmune diseases

Rebif Spells Relief
01.10.1997

Clinical trials of the multiple sclerosis drug, Rebif, are proving its effectiveness

Pages